- CA$800.35m
- CA$1.33bn
- $1.15bn
- 65
- 99
- 40
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,384 | 649 | 894 | 1,271 | 1,149 |
Cost of Revenue | |||||
Gross Profit | 676 | 71.7 | 478 | 702 | 498 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,242 | 1,100 | 68.9 | 627 | 994 |
Operating Profit | 141 | -451 | 825 | 643 | 154 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 158 | -449 | 637 | 540 | 197 |
Provision for Income Taxes | |||||
Net Income After Taxes | 306 | -482 | 636 | 291 | 193 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 294 | -497 | 628 | 287 | 193 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 294 | -497 | 628 | 287 | 193 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.43 | -3.75 | 0.992 | 1.92 | 2.56 |
Dividends per Share | |||||
Special Dividends per Share |